← All stocks

ANI PHARMACEUTICALS INC

ANIP Scheduled selling only
CIK 0001023024 #2131 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.10M
$1.10M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 5 sales
Net
−$1.10M
$0.00 against sales at will

By person

16 insiders · 5 transactions
28.7×

Nikhil Lalwani holds 28.7 times base salary in stock. $24.08M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $71.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lalwani Nikhil
PRESIDENT & CEO
$784.62K (2) scheduled
−$784.62K
339,089
1.51%
$24.08M
−9.3%
CAREY STEPHEN P.
SVP & CFO
$207.48K (1) scheduled
−$207.48K
171,843
0.7640%
$12.20M
+6.1%
Thoma Jeanne
Director
$71.53K (1) scheduled
−$71.53K
26,762
0.1190%
$1.90M
−34.1%
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
$35.40K (1) scheduled
−$35.40K
73,924
0.3287%
$5.25M
+30.3%
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
532,976
2.37%
$37.84M
−24.0%
Gassert Chad
SVP - CORP. DEV. & STRATEGY
233,406
1.04%
$16.57M
−3.9%
Mutz Christopher
HEAD OF RARE DISEASE
91,309
0.4060%
$6.48M
+9.6%
Gutwerg Ori
SVP, GENERICS
75,534
0.3358%
$5.36M
−2.2%
Davis Krista
SVP, CHIEF HR OFFICER
51,946
0.2310%
$3.69M
+3.8%
HAUGHEY THOMAS
Director
38,878
0.1729%
$2.76M
−24.5%
Walsh Patrick D
Director
38,432
0.1709%
$2.73M
−48.6%
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
38,271
0.1702%
$2.72M
+9.6%
TANNENBAUM RENEE P
Director
29,514
0.1312%
$2.10M
+30.5%
Pera Antonio R
Director
27,017
0.1201%
$1.92M
−13.0%
Leonard Matthew J
Director
11,221
0.0499%
$796.69K
−6.4%
Gosebruch Henry O
Director
6,662
0.0296%
$473.00K
Insider
Date
Role
Action
Shares
Price
Amount
Lalwani Nikhil
15 Sep 2026
PRESIDENT & CEO
Sold on a plan
5,400
$71.00
$383.40K
Cook Meredith
14 Sep 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$70.79
$35.40K
Thoma Jeanne
11 Sep 2026
Director
Sold on a plan
1,000
$71.53
$71.53K
CAREY STEPHEN P.
31 Aug 2026
SVP & CFO
Sold on a plan
2,850
$72.80
$207.48K
Lalwani Nikhil
25 Aug 2026
PRESIDENT & CEO
Sold on a plan
5,400
$74.30
$401.22K

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 6,662
History held since 16 Nov 2016